ReviewInternational journal of women's health2025
Pharmacists' Role in HPV Vaccine Uptake Among Women: A Scoping Review of Interventions and Barriers.
Review in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human papillomavirus (HPV) is a leading cause of cervical cancer among women worldwide. Although HPV vaccination is proven to be safe and effective, global coverage remains suboptimal, with substantial disparities between high-income and lower-middle-income countries. Recent evidence indicates that HPV vaccine uptake in upper-middle-income countries is considerably higher than in lower-middle-income countries, reflecting persistent inequities in vaccine access. Pharmacists, as accessible and trusted healthcare professionals, have been increasingly recognized for their potential roles in supporting HPV vaccination through education, counseling, and vaccine administration. This scoping review, conducted in accordance with the PRISMA-ScR framework, aimed to explore how pharmacists influence HPV vaccine uptake among women by identifying their roles, assessing their impact on vaccination-related outcomes, and examining implementation challenges. A comprehensive search of PubMed and Scopus databases was performed. A total of 24 studies were included in this review. The majority of studies originated from high-income countries, particularly the United States, where pharmacists are authorized to provide immunization services. Nine studies reported pharmacist-led interventions such as public education, individualized counseling on the importance of vaccination for parents/caregivers, outreach messaging, and vaccine administration, which demonstrated improvements in awareness, vaccination intent, and HPV uptake. The remaining studies assessed pharmacists' knowledge, attitudes, readiness, and perceived barriers related to the provision of immunization services, including limited training, unclear legal authority, and workload constraints. Overall, this review underscores the important contribution of pharmacists in HPV vaccination delivery. When adequately supported by education, infrastructure, and policy, pharmacists can serve as key partners in expanding equitable access to HPV vaccination and advancing cervical cancer prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.